ENYO Pharma Funding: $102M Raised, Series C (2024)

ENYO Pharma funding overview

ENYO Pharma is based in Lyon, France. ENYO Pharma has raised $102M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in January 2024. The round record for ENYO Pharma runs through 2024; nothing later has been disclosed. Investors on record include OrbiMed, Morningside Ventures, Andera Partners, Bpifrance, Vesalius Biocapital IV, Sofinnova Partners and 7 others. 13 distinct backers are named across the disclosed rounds.

ENYO Pharma at a glance

Total raised: $102M
Latest round: Series C
Latest round date: January 2024
Headquarters: Lyon, France
Notable investors: OrbiMed, Morningside Ventures, Andera Partners, Bpifrance, Vesalius Biocapital IV, Sofinnova Partners, Earlybird Venture Capital, Kurma Partners

Frequently asked about ENYO Pharma funding

How much has ENYO Pharma raised?: ENYO Pharma has raised $102M in total disclosed funding across the rounds on record.
Who has invested in ENYO Pharma?: OrbiMed, Morningside Ventures, Andera Partners, Bpifrance, Vesalius Biocapital IV, Sofinnova Partners are named among the investors backing ENYO Pharma.
What was the latest ENYO Pharma funding round?: The most recent disclosed round is a Series C, announced in January 2024.
Where is ENYO Pharma based?: ENYO Pharma is based in Lyon, France.
When did ENYO Pharma last raise?: The last disclosed ENYO Pharma round closed in January 2024 at Series C.

Every ENYO Pharma figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Lyon at a similar stage.

ENYO Pharma Funding: $102M Raised, Series C (2024)

ENYO Pharma funding overview

ENYO Pharma at a glance

Frequently asked about ENYO Pharma funding

Companies related to ENYO Pharma (36)

Browse related funding lists (6)